Skip to content

Prospective comparison of endoscopic subcutaneous mastectomy plus immediate reconstruction with implants versus breast conserving surgery for breast?cancer

Prospective comparison of endoscopic subcutaneous mastectomy plus immediate reconstruction with implants versus breast conserving surgery for breast?cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-TNRC-09000329
Enrollment
Unknown
Registered
2009-02-16
Start date
2007-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

ESM group:Endoscopic subcutaneous mastectomy with axillary l
BCS group:Breast conserving surgery

Sponsors

Southwest Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 55 Years

Inclusion criteria

Inclusion criteria: female; age <55 years; invasive breast cancer confirmed histopathologically by preoperative core needle biopsy or excision biopsy; the largest tumor diameter smaller than 3 cm primarily or after neoadjuvant chemotherapy; no deviation or retraction of nipple; no obviously enlarged or fused axillary lymph nodes; no distant metastasis found by auxiliary examination; consent of neoadjuvant chemotherapy with TE regimen (taxol 175 mg/m2, epirubicin 80 mg/m2, IV day 1; cycled every 21 days for 1-4 cycles).

Exclusion criteria

Exclusion criteria: age >55 years; with deviation or retraction of nipple; with obviously enlarged or fused axillary lymph nodes; with distant metastasis found by auxiliary examination; rejection of neoadjuvant chemotherapy with TE regimen (taxol 175 mg/m2, epirubicin 80 mg/m2, IV day 1; cycled every 21 days for 1-4 cycles); the largest tumor diameter larger than 3 cm primarily or after neoadjuvant chemotherapy.

Design outcomes

Primary

MeasureTime frame
Disease-free survival rate;Total survival rate;Postoperative cosmetic satisfaction rate;

Secondary

MeasureTime frame
Postoperative complication rate;

Countries

China

Contacts

Public ContactLinjun FAN
flj212@medmail.com.cn+86 0 13389668035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026